Clinical trial
Autologous CD34+ Stem Cell Injection for Severe Intermittent Claudication (Leg…
NCT00311805 · Losordo, Douglas, M.D., Other · Unknown status
Key facts
| NCT number | NCT00311805 |
|---|---|
| Title | Autologous CD34+ Stem Cell Injection for Severe Intermittent Claudication (Leg Pain) |
| Official title | Injection of Autologous CD34-Positive Stem Cells for Neovascularization and Symptom Relief in Patients With Severe Intermittent Claudication |
| Lead sponsor | Losordo, Douglas, M.D., Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Peripheral Artery Disease, Severe Intermittent Claudication |
| Intervention type | Biological |
| Interventions | Autologous Stem Cells (CD34+) |
| Enrollment | 24 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2012 |
| First posted | Apr 6, 2006 |
| Last update posted | Mar 31, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: